no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Animal models for protein pneumococcal vaccine evaluation: A summary
|
Steinhoff, M.C. |
|
2007 |
25 |
13 |
p. 2465-2470 6 p. |
article |
2 |
An overview of acute otitis media in Australian Aboriginal children living in remote communities
|
Morris, P.S. |
|
2007 |
25 |
13 |
p. 2389-2393 5 p. |
article |
3 |
Brief review of the clinical effectiveness of PREVENAR® against otitis media
|
Fletcher, Mark A. |
|
2007 |
25 |
13 |
p. 2507-2512 6 p. |
article |
4 |
Central nervous system infection is an important cause of death in underfives hospitalised with World Health Organization (WHO) defined severe and very severe pneumonia
|
Lupisan, Socorro P. |
|
2007 |
25 |
13 |
p. 2437-2444 8 p. |
article |
5 |
Changing epidemiology of invasive pneumococcal disease in central Australia prior to conjugate vaccine: A 16-year study
|
Torzillo, Paul J. |
|
2007 |
25 |
13 |
p. 2375-2378 4 p. |
article |
6 |
Children exposed to environmental smoking have a higher antibiotic consumption
|
Nilsson, Percy |
|
2007 |
25 |
13 |
p. 2533-2535 3 p. |
article |
7 |
Clear not simple: An approach to community consultation for a maternal pneumococcal vaccine trial among Indigenous women in the Northern Territory of Australia
|
Dunbar, M. |
|
2007 |
25 |
13 |
p. 2385-2388 4 p. |
article |
8 |
Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: Otitis media and acute pneumonia
|
Cripps, Allan W. |
|
2007 |
25 |
13 |
p. 2471-2477 7 p. |
article |
9 |
Contrasting roles for reactive oxygen species and nitric oxide in the innate response to pulmonary infection with Streptococcus pneumoniae
|
Marriott, Helen M. |
|
2007 |
25 |
13 |
p. 2485-2490 6 p. |
article |
10 |
Contributions of Native Americans to the global control of infectious diseases
|
Santosham, Mathuram |
|
2007 |
25 |
13 |
p. 2366-2374 9 p. |
article |
11 |
Developing an ELISA using serotype-specific antigens from selected pneumococcal strains of own selection
|
Slotved, H.-C. |
|
2007 |
25 |
13 |
p. 2513-2517 5 p. |
article |
12 |
Development of lactococcal GEM-based pneumococcal vaccines
|
Audouy, Sandrine A.L. |
|
2007 |
25 |
13 |
p. 2497-2506 10 p. |
article |
13 |
Editorial Board
|
|
|
2007 |
25 |
13 |
p. CO2- 1 p. |
article |
14 |
Efficacy of a novel oral carbapenem, tebipenem pivoxil (TBM-PI), against experimental otitis media caused by penicillin resistant Streptococcus pneumoniae in chinchilla
|
Hotomi, Muneki |
|
2007 |
25 |
13 |
p. 2478-2484 7 p. |
article |
15 |
Fifth International Symposium on Pneumococci and Pneumococcal Diseases, Alice Springs, Central Australia, 2–6 April 2006
|
Cripps, Allan W. |
|
2007 |
25 |
13 |
p. 2361-2365 5 p. |
article |
16 |
Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
|
Giele, Carolien |
|
2007 |
25 |
13 |
p. 2379-2384 6 p. |
article |
17 |
Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs
|
van den Dobbelsteen, Germie P.J.M. |
|
2007 |
25 |
13 |
p. 2491-2496 6 p. |
article |
18 |
Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar)
|
Isaacman, Daniel J |
|
2007 |
25 |
13 |
p. 2420-2427 8 p. |
article |
19 |
Indirect effects of childhood pneumococcal vaccination on pneumococcal carriage among adults and older children in Australian Aboriginal communities
|
Mackenzie, Grant |
|
2007 |
25 |
13 |
p. 2428-2433 6 p. |
article |
20 |
Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine
|
Madhi, Shabir A. |
|
2007 |
25 |
13 |
p. 2451-2457 7 p. |
article |
21 |
Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract
|
Jacoby, Peter |
|
2007 |
25 |
13 |
p. 2458-2464 7 p. |
article |
22 |
Molecular characterisation of pneumococcal serotype 16F: Established predominant carriage and otitis media serotype in the 7vPCV era
|
Marsh, R.L. |
|
2007 |
25 |
13 |
p. 2434-2436 3 p. |
article |
23 |
Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly
|
Örtqvist, Å. |
|
2007 |
25 |
13 |
p. 2445-2450 6 p. |
article |
24 |
Perspectives on the burden of pneumonia in children
|
Mulholland, Kim |
|
2007 |
25 |
13 |
p. 2394-2397 4 p. |
article |
25 |
Radiology quality assurance in a developing country setting: The 11-valent pneumococcal conjugate vaccine trial, Bohol, Philippines
|
Arcay, Jose D. |
|
2007 |
25 |
13 |
p. 2528-2532 5 p. |
article |
26 |
The preventable burden of pneumococcal disease in the developing world
|
Scott, J.A.G. |
|
2007 |
25 |
13 |
p. 2398-2405 8 p. |
article |
27 |
The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease
|
Hausdorff, William P. |
|
2007 |
25 |
13 |
p. 2406-2412 7 p. |
article |
28 |
Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children
|
Henckaerts, Isabelle |
|
2007 |
25 |
13 |
p. 2518-2527 10 p. |
article |
29 |
World Health Organisation definition of “radiologically-confirmed pneumonia” may under-estimate the true public health value of conjugate pneumococcal vaccines
|
Madhi, Shabir A. |
|
2007 |
25 |
13 |
p. 2413-2419 7 p. |
article |